2022
DOI: 10.1177/10781552211073778
|View full text |Cite
|
Sign up to set email alerts
|

Impact of the COVID-19 pandemic on new starts to oral oncology medications in the US

Abstract: Introduction The COVID-19 pandemic has had a significant impact on healthcare delivery. Although others have documented the impact on new cancer diagnoses, trends in new starts for oncology drugs are less clear. We examined changes in new users of oral oncology medications in the US following COVID-19 stay-at-home orders in 2020 compared to prior years. Methods We examined prescription data for members enrolled with a national pharmacy benefits manager in the US from January 1-October 31 of 2018, 2019, and/or … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…The curtailment of normal clinical activities in Pakistani hospitals to limit the spread of COVID-19 had led to disruptions in the care of cancer patients [ 8 ]. Although the long-term implications of delays and disruptions in health care services for cancer patients are yet to be seen, there is concern that patient outcomes may be negatively impacted [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…The curtailment of normal clinical activities in Pakistani hospitals to limit the spread of COVID-19 had led to disruptions in the care of cancer patients [ 8 ]. Although the long-term implications of delays and disruptions in health care services for cancer patients are yet to be seen, there is concern that patient outcomes may be negatively impacted [ 9 ].…”
Section: Introductionmentioning
confidence: 99%